ストックスクリーナーアプリを入手
0.8692
25.07%
-0.2908
アフターアワーズ：
.88
0.0108
+1.24%
前日終値:
$1.16
開ける：
$1.15
24時間の取引高:
4.15M
Relative Volume:
3.06
時価総額：
$51.10M
収益：
-
当期純損益:
$-123.46M
株価収益率:
-0.3356
EPS:
-2.59
ネットキャッシュフロー:
$-104.11M
1週間 パフォーマンス:
+10.03%
1か月 パフォーマンス:
+25.97%
6か月 パフォーマンス:
+127.42%
1年 パフォーマンス:
-37.47%
1日の値動き範囲:
$0.84
$1.19
1週間の範囲:
$0.82
$1.43
52週間の値動き範囲:
$0.2601
$1.90
Bioatla Inc Stock (BCAB) Company Profile
BCAB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.8692 | 68.20M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-13 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-05-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-06-28 | 開始されました | ROTH Capital | Buy |
| 2021-05-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-01-11 | 開始されました | BTIG Research | Buy |
| 2021-01-11 | 開始されました | Credit Suisse | Outperform |
| 2021-01-11 | 開始されました | JP Morgan | Overweight |
| 2021-01-11 | 開始されました | Jefferies | Buy |
すべてを表示
Bioatla Inc (BCAB) 最新ニュース
Form 424B5 BioAtla, Inc. - StreetInsider
BioAtla Secures $7.5 Million Pre-Paid Advance - TipRanks
BioAtla’s New Funding: A Double-Edged Sword for Shareholders - Ad-hoc-news.de
BioAtla Agrees to $22.5 Million in Financing Agreements - MarketScreener
BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing - Investing News Network
BioAtla, Inc. Secures $7.5 Million Financing to Support Operations During Strategic Partnership Negotiations - Quiver Quantitative
BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing - GlobeNewswire Inc.
Is BioAtla Inc (BCAB) Good For Your Portfolio? - fostersleader.com
Regression analysis insights on BioAtla Inc. performanceWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
What catalysts could drive BioAtla Inc. stock higherProfit Target & Fast Gain Swing Trade Alerts - newser.com
Measuring BioAtla Inc.’s beta against major indicesTrade Analysis Report & Community Consensus Trade Alerts - newser.com
BioAtla Inc. stock outlook for YEAR2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - newser.com
Bioatla Shares Surge on Strong Clinical and Financial Results - Ad-hoc-news.de
Sentiment analysis tools applied to BioAtla Inc.Take Profit & Verified Momentum Watchlists - newser.com
What moving averages say about BioAtla Inc.Portfolio Return Summary & Accurate Entry/Exit Alerts - newser.com
BioAtla Inc (BCAB) can make a big difference with a little luck - Setenews
Analyzing BioAtla Inc. with multi timeframe chartsMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
Analyzing BioAtla Inc. with risk reward ratio chartsTrade Performance Summary & Weekly Watchlist of Top Performers - newser.com
What to do if you’re stuck in BioAtla Inc.Sell Signal & Reliable Price Action Trade Plans - newser.com
Chart overlay techniques for tracking BioAtla Inc.July 2025 Sentiment & Technical Confirmation Alerts - newser.com
Is BioAtla Inc. a candidate for recovery playGap Down & AI Powered Trade Plan Recommendations - newser.com
BioAtla, Inc. (NASDAQ:BCAB) Q3 2025 Earnings Call Transcript - Insider Monkey
BioAtla Tightens Belt But Analysts Remain Upbeat - Finimize
BioAtla Reports Q3 2025 Financial Results and Progress - TipRanks
BioAtla Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Bioatla Q3 2025 shows stable EPS, stock dips - Investing.com India
BioAtla (BCAB) Q3 2025 Earnings Call Transcript - AOL.com
BioAtla, Inc. Q3 Earnings Call Highlights Progress and Challenges - TipRanks
Transcript : BioAtla, Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener
Earnings call transcript: Bioatla Q3 2025 shows stable EPS, stock dips By Investing.com - Investing.com Canada
BioAtla Inc (BCAB) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Promising Trial ... By GuruFocus - Investing.com Canada
BioAtla Q3 net loss widens to $15.8 mln - MarketScreener
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Investing News Network
BioAtla, Inc. (BCAB) Q3 FY2025 earnings call transcript - Yahoo Finance
Press Release: BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - 富途牛牛
What analysts say about BioAtla Inc stockMean Reversion Trades & Explosive Profit Trading - earlytimes.in
Bioatla Inc (BCAB) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):